FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Aug 1, 2024
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on August 1, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6311e5cb-22a0-469d-9c2e-449274d6c4fd
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1243362
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Baxter Healthcare Corporation
19| Date | Classification | Office | Project area |
|---|---|---|---|
| April 2, 2026 | Not classified | Chicago District Office | Drug Quality Assurance |
| November 25, 2025 | Not classified | Chicago District Office | Blood and Blood Products |
| August 18, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 26, 2018 | Not classified | Chicago District Office | |
| July 14, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1311078 - 2026-04-02
- FDA Inspection 1293034 - 2025-11-25
- FDA Inspection 1215194 - 2023-08-18
- FDA Inspection 1068273 - 2018-09-26
- FDA Inspection 1024072 - 2017-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.